miR-216a/217 prompted migration and metastatic ability and increased the stem-like cells population and tumor recurrence in HCC by activation of PI3K/Akt and TGF-β pathways by induction of targeting PTEN and SMAD7 expression [185]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.